TABLE 4.
Health Care Resource Utilization During Baseline and Study Periods a
| Telaprevir Patients (n = 871) | Boceprevir Patients (n = 284) | |
|---|---|---|
| Baseline period (6 months) | ||
| At least 1 visit, n (%) | ||
| IP visits | 38 (4.4) | 15 (5.3) |
| ER visits | 105 (12.1) | 44 (15.5) |
| OP visits | 866 (99.4) | 276 (97.2) |
| Number of visits, mean ± SD | ||
| IP visits | 0.1 ± 0.3 | 0.1 ± 0.3 |
| ER visits | 0.2 ± 0.5 | 0.2 ± 0.5 |
| OP visits | 10.6 ±9.3 | 9.5 ± 7.0 |
| Drug prescriptions for CHC treatment | ||
| At least 1 drug prescription, n (%) | 154 (17.7) | 93 (32.8) |
| Number of drug prescriptions, mean ± SD | 0.5 ± 1.5 | 1.2 ± 2.6 |
| Study period (12 months) | ||
| At least 1 visit, n (%) | ||
| IP visits | 151 (17.3) | 47 (16.5) |
| ER visits | 242 (27.8) | 86 (30.3) |
| OP visits | 871 (100.0) | 282 (99.3) |
| Number of visits, mean ± SD | ||
| IP visits | 0.3 ± 0.9 | 0.2 ± 0.7 |
| ER visits | 0.5 ± 1.2 | 0.5 ± 1.3 |
| OP visits | 29.1 ± 18.6 | 29.9 ± 16.9 |
| Drug prescriptions for CHC treatment | ||
| At least 1 drug prescription, n (%) | 871 (100.0) | 284 (100.0) |
| Number of drug prescriptions, mean ± SD | 15.2 ±8.0 | 18.9 ± 9.5 |
a The baseline period was defined as 6 months before the index date, and the study period was defined as 12 months after the index date.
CHC = chronic hepatitis C; ER = emergency room; IP = inpatient; OP = outpatient; SD = standard deviation.